Gregor B. E. Jemec

University of Copenhagen — Denmark

Medicine · Health Sciences

101h-index40.7kcitations1.0kworks4.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hidradenitis Suppurativa and Treatments(384), Colorectal and Anal Carcinomas(297), Chemotherapy-related skin toxicity(125), Dermatology and Skin Diseases(121), Cutaneous Melanoma Detection and Management(102)

Publications1.0k total

Stress in dermatology patients: A multicenter observational study of 8295 outpatients and controls from 22 European clinics
JAAD International·2025Open Access
Hidradenitis Suppurativa and Smoking, Obesity, Psoriasis, Inflammatory Bowel Disease, and Systemic Sclerosis
JAMA Dermatology·2025Open Access
Advanced <scp>CYLD</scp> Cutaneous Syndrome ( <scp>CCS</scp> ) Treated With the Hedgehog Signaling Pathway Inhibitor Vismodegib Results in a Limited Clinical Response
Apmis·2025
Hidradenitis Suppurativa Remission and Progression in a Community Setting
JAMA Dermatology·2025Open Access
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa
JAMA Dermatology·2025· 1 cited
Bimekizumab demonstrated a favorable safety profile and high levels of efficacy with up to 2 years of treatment in patients with moderate to severe hidradenitis suppurativa: Pooled results from two phase 3 randomized, controlled trials and their open-label extension
Journal of the American Academy of Dermatology·2025· 1 citedOpen Access
Towards the development of upgrade criteria for the treatment of hidradenitis suppurativa with biologics
Journal of the European Academy of Dermatology and Venereology·2025· 2 citedOpen Access
A High Estimated Prevalence of Onychomycosis Exists Among Danish Children
Mycoses·2025Open Access
Why Do You Want to See a Dermatologist?
Dermatology·2025
Dermatophyte contamination of hair clippers and cleaning brushes in Copenhagen hair salons
Journal of the European Academy of Dermatology and Venereology·2025· 1 cited
Vilobelimab to improve clinical outcomes in moderate-to-severe hidradenitis suppurativa through an adjunctive effect on draining tunnels: results of the SHINE double-blind placebo-controlled randomized trial
British Journal of Dermatology·2025· 2 citedOpen Access
Management of Severe Bilateral Axillary Hidradenitis Suppurativa in a Resource‐Limited Setting: A Case Report and Review of the Literature
Clinical Case Reports·2025Open Access
Grand challenges for skin health revisited: the International League of Dermatological Societies skin disease atlases
British Journal of Dermatology·2025· 1 citedOpen Access
It is still a secret disease – clinical images in randomized controlled trials on hidradenitis suppurativa
Journal of Dermatological Treatment·2025Open Access
62149 The impact of continuous secukinumab treatment between weeks 52–104 on HiSCR75, HiSCR90, and HiSCR100 in patients with moderate to severe hidradenitis suppurativa: A post hoc analysis of the SUNSHINE and SUNRISE extension trial
Journal of the American Academy of Dermatology·2025
63331 Bimekizumab safety and tolerability in patients with moderate to severe hidradenitis suppurativa: 2-year results from BE HEARD EXT
Journal of the American Academy of Dermatology·2025
Prevalence of Hidradenitis Suppurativa
JAMA Dermatology·2025· 6 citedOpen Access
Establishment of standardized definitions and a core set of outcome characteristics following hidradenitis suppurativa surgery developed by an expert Delphi consensus
Journal of the American Academy of Dermatology·2025· 1 citedOpen Access
Secukinumab in the Treatment of Moderate‐to‐Severe Hidradenitis Suppurativa: Pooled Pharmacokinetics and Safety Results From the <scp>SUNSHINE</scp> and <scp>SUNRISE</scp> Phase 3 Studies
International Journal of Dermatology·2025· 1 citedOpen Access
The HIdradenitis suppurativa DrainagE (HIDE) scale: development and content validation of a patient reported outcome measure
British Journal of Dermatology·2025· 2 cited
page 1 of 51Next →

Frequent Co-authors

Christos C. Zouboulis(13), Errol P. Prens(11), Hessel H. van der Zee(9), Alexa B. Kimball(9), Lennart Emtestam(7), Jan Lapins(6), Thrasyvoulos Tzellos(6), Falk G. Bechara(6), Łukasz Matusiak(5), Jacek C. Szepietowski(5), Evangelos J. Giamarellos‐Bourboulis(5), Karin Sartorius(5), Jurr Boer(5), V. del Mármol(4), I.M. Miller(4), Solveig Esmann(4), Robert E. Hunger(3), J. Revuz(3), Martin M. Okun(3), Ditte Marie Lindhardt Saunte(3)